venofer dosing calculator

Untreated IDA in pregnancy is associated with adverse maternal outcomes such as post-partum anemia. Administer while the patient is in a reclined or semi-reclined position. Dosing Administration & Considerations . iron sucrose increases levels of calcium citrate by enhancing GI absorption. Dosage: For patients weighing 50 kg (110 lb) or more: Give Injectafer in two doses separated by at least 7 days. Deferiprone may bind polyvalent cations (eg, iron, aluminum, and zinc), separate administration by at least 4 hr between deferiprone and other medications (eg, antacids), or supplements containing these polyvalent cations. Use Caution/Monitor. The weight of the patient is taken into account in order to estimate iron stores, while haemoglobin is required as both current measured and target. Applies only to oral form of both agents. Avoid or Use Alternate Drug. 2 *Venofer is an iron replacement product indicated for the treatment of iron deficiency anemia in patients with CKD. Injectafer treatment may be repeated if iron deficiency anemia reoccurs. Parenteral iron product is iron sucrose (C = 20 mg elemental iron/mL). Auerbach M, Witt D, Toler W, Fierstein M, Lerner RG, Ballard H. Clinical use of the total dose intravenous infusion of iron dextran. Applies only to oral form of both agents. When administering as a slow intravenous push, give at the rate of approximately 100 mg (2 mL) per minute. Ferric gluconate: 12.5 mg/mL Schrier SL, Mentzer WC, Landaw SA. This iron deficiency calculator determines the iron deficit based on patient weight, hemoglobin and iron stores to prepare for iron replacement. Applies only to oral form of both agents. Hemoglobin iron deficit = 60 x (14 - 8) x (2.145) = 772 mg iron. Echocardiogram Z Score (NEW)(BETA TESTING) Edinburgh Postnatal Depression Scale. Monitor patients for signs and symptoms of hypersensitivity during and after Venofer administration for at least 30 minutes and until clinically stable following completion of the infusion. For patients receiving hemodialysis, administer Feraheme once the blood pressure is stable and the patient has completed at least one hour of hemodialysis. INFeD is given undiluted at a slow gradual rate not to exceed 50 mg (1 mL) per minute. Copyright 2014 - 2023 The Calculator .CO |All Rights Reserved|Terms and Conditions of Use, Parenteral Iron Replacement For Iron Deficiency Anemia Calculator, Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations, Clinical use of the total dose intravenous infusion of iron dextran, When is high-dose intravenous iron repletion needed? The dosage of Venofer is expressed in mg of elemental iron. Inspect parenteral drug products visually for the absence of particulate matter and discoloration prior to administration. Safety of highdose iron sucrose infusion in hospitalized patients with chronic kidney disease. Use Caution/Monitor. Use Caution/Monitor. Applies only to oral form of both agents. Applies only to oral form of both agents. In the text below the tool there is more information on how the iron deficit is calculated. Corrected Sodium and Effective Osmolality. This website is intended for use by US healthcare professionals only. Give each dose as 750 mg for a total cumulative dose of 1500 mg of iron per course. Human studies not conducted. For repletion treatment most patients may require a cumulative dose of 1000 mg of elemental iron administered over 8 dialysis sessions. . Before using, check this product visually for particles or discoloration. Modify Therapy/Monitor Closely. STORAGE: Consult the product instructions and your pharmacist for storage details. Applies only to oral form of both agents. Use Caution/Monitor. iron sucrose decreases levels of deferiprone by enhancing GI absorption. We first individually analyzed 5 clinical studies, averaging the total iron deficit across all patients utilizing a . Copyright 2021 GlobalRPH - Web Development by, Calculation of the Total Iron Deficit Alternative equation. Most reactions associated with intravenous iron preparations occur within 30 minutes of the completion of the infusion. 2012;2(4):288-335. 2) Koch TA, Myers J, Goodnough LT. (2015) Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations. Applies only to oral form of both agents. Ferrlecit has been administered at sequential dialysis sessions by infusion or by slow intravenous injection during the dialysis session itself. Serious - Use Alternative (1)iron sucrose decreases levels of tetracycline by inhibition of GI absorption. Applies only to oral form of both agents. Applies only to oral form of both agents. Option 2: 200 mg in NS 100 mL administered over 20-30 minutes; may repeat every other day to The dosing for iron replacement treatment in pediatric patients with NDD-CKD or PDD-CKD has not been established. Intravenous therapy is preferred for urgent intervention and when oral iron cannot be absorbed or the patient suffers from chronic renal impairment. omeprazole will decrease the level or effect of iron sucrose by increasing gastric pH. Either increases effects of the other by pharmacodynamic synergism. 2010;18(3). Maintain a well-balanced diet, and follow any dietary guidelines as directed by your doctor. In most cases, adult patients require a cumulative dose of elemental iron of at least 1 g. Most commonly, iron replenishment therapy is done intravenously: As total dose (iron-dextran or iron carboxymaltose); Iron deficiency is common during childhood growth, prolonged periods of sickness, in convalescence or during pregnancy. Talk to your pharmacist for more details.During pregnancy, this medication should be used only when clearly needed. Burns DL, Mascioli EA, Bistrian BR. Applies only to oral form of both agents. Serious - Use Alternative (1)iron sucrose decreases levels of mycophenolate by inhibition of GI absorption. Pasricha SR, Flecknoe-Brown SC, Allen KJ, Gibson PR, McMahon LP, Olynyk JK, Roger SD, Savoia HF, Tampi R, Thomson AR, Wood EM, Robinson KL. (3) Known hypersensitivity to Venofer. Venofer must only be administered intravenously either by slow injection or by infusion. Applies only to oral form of both agents. Copyright 2014 - 2023 The Calculator .CO |All Rights Reserved|Terms and Conditions of Use, Intravenous iron-dextran: therapeutic and experimental possibilities, Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations, Treatment of iron deficiency anemia associated with gastrointestinal tract diseases, Diagnosis and management of iron deficiency anaemia: a clinical update. Serious - Use Alternative (1)iron sucrose decreases levels of eltrombopag by inhibition of GI absorption. Only administer Feraheme as an intravenous infusion over at least 15 minutes and only when personnel and therapies are immediately available for the treatment of anaphylaxis and other hypersensitivity reactions. Total cumulative Venofer dose = number of 100mg ampoules for Hb increase. Discuss the risks and benefits with your doctor.This medication passes into breast milk. Please note that once you have closed the PDF you need to click on the Calculate button before you try opening it again, otherwise the input and/or results may not appear in the pdf. Applies only to oral form of both agents. Applies only to oral form of both agents. Administer Venofer 100 mg undiluted as a slow intravenous injection over 2 to 5 minutes, or as an infusion of 100 mg diluted in a maximum of 100 mL of 0.9% NaCl over a period of at least 15 minutes, per consecutive hemodialysis session [see How Supplied/Storage and Handling (16.2).] This drug is available at a higher level co-pay. Discard unused portion. Hemoglobin can be input in g/dL, g/L or mmol/L and refers to the amount of hemoglobin in the red blood cells. Anemia; 2015: 763576. Many patients with kidney disease cannot get enough iron from food and require injections. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Applies only to oral form of both agents. Applies only to oral form of both agents. Applies only to oral form of both agents. In less advanced cases of iron deficiency, increases in dietary intake of iron may be sufficient. Official Journal of the International Society of Nephrology. Copyright(c) 2023 First Databank, Inc. Applies only to oral form of both agents. The total amount of INFeD in mL required to treat the anemia and replenish iron stores may be approximated as follows: Adults and Children over 15 kg (33 lbs): See Dosage Table. Where C= concentration of Use Caution/Monitor. 1000 mg. 20 MINUTES. The plasma ferritin level as a reliable index of body iron stores following intravenous iron dextran. Fatal reactions have followed the test dose of iron dextran injection. Interaction only with oral iron administration. iron sucrose will decrease the level or effect of omadacycline by inhibition of GI absorption. iron sucrose increases levels of calcium acetate by enhancing GI absorption. Either decreases levels of the other by inhibition of GI absorption. Applies only to oral form of both agents. Applies only to oral form of both agents. Adults and Children over 15 kg (33 lbs): Dose (mL) = 0.0442 (Desired Hb - Observed Hb) x LBW + (0.26 x LBW), Desired Hb = the target Hb in g/dl. Calculation of total iron deficit for initial repletion: [29] Total cumulative dose (mg) = [Target Hb Actual Hb] weight (kg) 2.4 + [15 weight (kg)] *Hb in g/dl: 2. Minor/Significance Unknown. SIDE EFFECTS: Muscle cramps, nausea, vomiting, strange taste in the mouth, diarrhea, constipation, headache, cough, back pain, joint pain, dizziness, or swelling of the arms/legs may occur. It is usually given slowly over 2 to 5 minutes or as directed by your doctor. Minor/Significance Unknown.iron sucrose increases levels of calcium chloride by enhancing GI absorption. In: Koda-Kimble & Young's Applied Therapeutics: The Clinical Use of Drugs. It is unlikely . (1970) Intravenous iron-dextran: therapeutic and experimental possibilities. Applies only to oral form of both agents. Medically reviewed by Drugs.com. Controlled studies in pregnant women show no evidence of fetal risk. Iron Product. Normal haemoglobin values are gender specific: for males from 13.8 to 18.0 g/dL (138 to 180 g/L, or 8.56 to 11.17mmol/L) and females from 12.1 to 15.1 g/dL (121 to 151 g/L, or 7.51 to 9.37mmol/L). The dosing of Monofer was performed according to the Simplified Table as described in section 4.2 above and dosing of iron sucrose was calculated according to Ganzoni and administered as 200 mg infusions. ANNA J. iron sucrose decreases levels of demeclocycline by inhibition of GI absorption. No data are available regarding overdosage of Venofer in humans. Multiple placebo-controlled, randomized clinical trials have been conducted with IV iron in patients with New York Heart Association class II-III heart failure with an ejection fraction 45% who met criteria . Use Caution/Monitor. Applies only to oral form of both agents. Venofer treatment may be repeated if iron deficiency reoccurs. Although anaphylactic reactions known to occur following INFeD administration are usually evident within a few minutes, or sooner, it is recommended that a period of an hour or longer elapse before the remainder of the initial therapeutic dose is given. Applies only to oral form of both agents. Monitor Closely (1)iron sucrose decreases levels of deferiprone by enhancing GI absorption. In post-marketing safety studies of Venofer in 1,051 patients with HDD-CKD, adverse reactions reported by >1% were cardiac failure congestive, sepsis and dysgeusia. Applies only to oral form of both agents. The factor 2.4 is derived from the following assumptions: a) Blood volume 70 ml/kg of body weight ~7% of body weight b) Iron content of hemoglobin 0.34% Factor 2.4 = 0.0034 x 0.07 x 10000 (conversion for g/dL) Ganzoni AM. For iron maintenance treatment: Administer Venofer at a dose of 0.5 mg/kg, not to exceed 100 mg per dose, every four weeks for 12 weeks given undiluted by slow intravenous injection over 5 minutes or Modify Therapy/Monitor Closely. Drug class: Iron products. The two formulas used are presented below: Iron deficit in mg = Weight in kg x (14 Hb in g/dL) x 2.145, Volume of product required in mL = Iron deficit in mg / C in mg/mL. 1982;13(4):309-21. Baloxavir may bind to polyvalent cations resulting in decreased absorption. The primary endpoint was the proportion of patients with . Hemodialysis-dependent: 0.5 mg/kg IV q2weeks for 12 weeks; not to exceed 100 mg/dose, Non-dialysis dependent or peritoneal-dependent (on erythropoietin): 0.5 mg/kg IV q4weeks for 12 weeks; not to exceed 100 mg/dose, sodium sulfate/?magnesium sulfate/potassium chloride, sodium sulfate/potassium sulfate/magnesium sulfate, Serious hypersensitivity reactions reported, including anaphylactic-type reactions, some of which have been life-threatening and fatal, Patients may present with shock, clinically significant hypotension, loss of consciousness, and/or collapse, If hypersensitivity reactions or signs of intolerance occur during administration, stop infusion immediately, Monitor patients for signs and symptoms of hypersensitivity during and after administration for at least 30 minutes and until clinically stable following completion of the infusion, Animal reproduction studies of iron sucrose administered to rats and rabbits during period of organogenesis at elemental iron doses equivalent to maximum recommended human dose based on body surface area revealed no evidence of harm to the fetus; adverse outcomes in pregnancy occur regardless of health of mother or use of medications, Iron deficiency anemia during pregnancy should be treated; untreated IDA in pregnancy is associated with adverse maternal outcomes such as post-partum anemia; adverse pregnancy outcomes associated with IDA include increased risk for preterm delivery and low birth weight, HD-dependent and non-dialysis-dependent CKD: Dilute with up to 100 mL of 0.9% NaCl, PD-dependent CKD: Dilute with up to 250 mL of 0.9% NaCl, Undiluted: Administer by slow IV injection over 2-5 min, Diluted solutions: Administer IV over 15 min, Undiluted: Administer by slow IV injection over 5 minutes, Diluted solutions: Administer IV over 5-60 minutes, Store in original carton at 20-25C (68-77 F); excursions permitted to 15- 30C (59-86F), Syringe: Store at room temperature (25C) or under refrigeration (4C) for up to 7 days, IV infusion: Store at room temperature (25C) for up to 7 days. Equations used: 1] Calculation of the Total Iron Deficit: Total iron deficit [mg] = body weight [kg] x (target Hb-actual Hb) [g/dl] x 2.4 + depot iron [mg]. Available for Android and iOS devices. Serious - Use Alternative (1)iron sucrose decreases levels of doxycycline by inhibition of GI absorption. Can't find what you need? Monitor Closely (1)iron sucrose decreases levels of ibandronate by inhibition of GI absorption. Dilute Venofer in a maximum of 250 mL of 0.9% NaCl [see How Supplied/Storage and Handling (16.2).] Use Caution/Monitor. The elemental iron product used is Iron sucrose 20 mg/mL. FOR PATIENTS WEIGHING LESS THAN 50 kg: Administer Monoferric as 20 mg/kg actual body weight by intravenous infusion 20 minutes . To provide clinicians with evidence-based guidance for iron therapy dosing in patients with iron deficiency anemia (IDA), we conducted a study examining the benefits of a higher cumulative dose of intravenous (IV) iron than what is typically administered. Venofer can be given as a maximum of 200mg not more than 3 times per week; doses must be 24 hours apart. Your doctor will do laboratory tests to monitor your response. Use Caution/Monitor. This parenteral iron replacement for iron deficiency anemia calculator determines the parenteral dose of iron supplement needed to replenish iron stores and hemoglobin levels. Avoid or Use Alternate Drug. Applies only to oral form of both agents. Monitor Closely (1)omeprazole will decrease the level or effect of iron sucrose by increasing gastric pH. IDA symptoms are often nonspecific and include tiredness, weakness, shortness of breath. Venofer (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of polynuclear iron (III)- . 0.5 mg/kg/min (0.005 mL/kg/min) Maximum infusion rate (if tolerated) Increase to 8 mg/kg/min (0.08 mL/kg/min) Monitor the patient's vital signs throughout the infusion. dexlansoprazole will decrease the level or effect of iron sucrose by increasing gastric pH. Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when Venofer is injected. March 2, 2015 [IRON SUCROSE REQUIREMENT CALCULATION FOR SEVERE ANEMIA] DPMU Anantapuramu | National Health Mission 1 Formula for calculating the required dose of Iron sucrose 2.4 X Pre-pregnancy Weight in Kgs X Hb% deficit{11-actual Hb%} in mgs Plus Iron required to replenish the iron stores = 500mg Prepregnancy Weight = 45 kgs . Although the original formula requires the weight in kilograms, values input in lbs are transformed. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9yZWZlcmVuY2UubWVkc2NhcGUuY29tL2RydWcvdmVub2Zlci1pcm9uLXN1Y3Jvc2UtMzQyMTYy, View explanations for tiers and -Hgb deficit (grams) = Hgb deficit (g/dL) x blood volume (dL) -Iron deficit (mg) = Hgb deficit (grams) x 3.3 (mg Fe/g Hgb) [Note: 3.3 x 0.65 = 2.145] Use Caution/Monitor. iron sucrose decreases levels of moxifloxacin by inhibition of GI absorption. FERAHEME met the predefined criteria for non-inferiority to Venofer . IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. If you log out, you will be required to enter your username and password the next time you visit. DOSAGE AND ADMINISTRATION: Oral iron should be discontinued prior to administration of INFeD. When administered via infusion, dilute up to 750 mg of iron in no more than 250 mL of sterile 0.9% sodium chloride injection, USP, such that the concentration of the infusion is not less than 2 mg of iron per mL and administer over at least 15 minutes. commonly, these are "preferred" (on formulary) brand drugs. Contraindicated. Minor/Significance Unknown.iron sucrose increases levels of calcium carbonate by enhancing GI absorption. lansoprazole will decrease the level or effect of iron sucrose by increasing gastric pH. Use Caution/Monitor. Pediatric Patients: The most common adverse reactions (2%) are headache, respiratory tract viral infection, peritonitis, vomiting, pyrexia, dizziness, cough, nausea, arteriovenous fistula thrombosis, hypotension and hypertension. Give each dose as 750 mg for a total cumulative dose not to exceed 1500 mg of iron per course. Use Caution/Monitor. Transferrin saturation (TSAT) values increase rapidly after intravenous administration of iron sucrose; do not perform serum iron measurements for at least 48 hours after intravenous dosing. Am J Kid Dis 2001; 38 988991. For iron maintenance treatment, administer Venofer, (2 years of age or older) with NDD-CKD or PDD-CKD who are on erythropoietin therapy for iron maintenance treatment. Ferric gluconate: 12.5 mg/mL. Minor (2)calcium gluconate decreases levels of iron sucrose by inhibition of GI absorption. Use Caution/Monitor.Minor (2)calcium carbonate decreases levels of iron sucrose by inhibition of GI absorption. Ferrlecit may be diluted in 100 mL of 0.9% sodium chloride administered by intravenous infusion over 1 hour per dialysis session. Applies only to oral form of both agents. Dose administration to an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy. (2010) Diagnosis and management of iron deficiency anaemia: a clinical update. Applies only to oral form of both agents. Venofer (iron sucrose) dose calculator | Calculosaurus.com Clinical calculators for obstetrics and gynaecology VTE risk assessment Calculator menu Venofer dose calculator Iron sucrose Not what you were looking for? The above information is provided for general 1970; 100(7):301-3. Share cases and questions with Physicians on Medscape consult. Minor/Significance Unknown. The therapeutic management of IDA focuses on the replenishment of the iron stores through methods that have been mentioned above. Venofer [package insert]. Your doctor will do laboratory tests to monitor your response. Please confirm that you would like to log out of Medscape. 1970;100(7):301303. The iron formulation choice remains for the clinician to make. J Lab Clin Med. The dosage is expressed in terms of mg of elemental iron, with each mL of Feraheme containing 30 mg of elemental iron. Mode of Administration: Administer Venofer only intravenously by slow injection or by infusion. nizatidine will decrease the level or effect of iron sucrose by increasing gastric pH. 1995 Mar-Apr;11(2):163-8. Taking the case of a patient weighing 75 kg (165.3 lbs) with a target hemoglobin value of 13 g/dL (130 g/L or 8.07 mmol/L), an actual hemoglobin of 9.5 g/dL (95 g/L or 5.9 mmol/L) and iron stores of 500 mg, the iron deficit is: Iron deficit = 75 x (13 9.5) x 2.4 + 500 = 1,130 mg. Applies only to oral form of both agents. 4)Pasricha SR, Flecknoe-Brown SC, Allen KJ, Gibson PR, McMahon LP, Olynyk JK, Roger SD, Savoia HF, Tampi R, Thomson AR, Wood EM, Robinson KL. Venofer is indicated for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD). Avoid or Use Alternate Drug. Our dosage calculator can help you with this as well. 1) Ganzoni AM. Brand name: Venofer Drug class: Iron Preparations Chemical name: iron saccharate CAS number: 8047-67-4 Medically reviewed by Drugs.com on Oct 25, 2022. The incidence of adverse events with the 400- and 500-mg doses administered as a 2-hour . Iron Deficiency Anemia: Periodic hematologic determination (hemoglobin and hematocrit) is a simple and accurate technique for monitoring hematological response, and should be used as a guide in therapy. Hemodialysis-dependent CKD: 100 mg elemental iron IV (injection or infusion over 2-5 min) per dialysis session not to exceed total cumulative dose of 1000 mg divided in 3 doses/week. Use Caution/Monitor. )If you are using this medication at home, learn all preparation and usage instructions from your health care professional. There are physiological variation in iron reserves such as the decrease during menstruation period. Intravenous iron-dextran: therapeutic and experimental possibilities [in German] Schweiz Med Wochenschr. calcium carbonate will decrease the level or effect of iron sucrose by increasing gastric pH. Contraindicated. LBW = Lean body weight in kg. Applies only to oral form of both agents. A healthcare provider will give you this injection. Deferasirox chelates iron. Anemia of chronic disease (ACD), Calculation of the Total Iron Deficit equation appears in Cosmofer PI, Iron Dextran Dosing Calculator (iron deficit). Each mL contains 20 mg of elemental iron. feasible, Maximum total cumulative iron sucrose dose administered in 14 days is 1000 mg elemental iron. Results: Twelve children (6 females) aged 1.2-14 years (median age 8.9 years) received at least one dose of . ibuprofen/famotidine will decrease the level or effect of iron sucrose by increasing gastric pH. Elemental iron product this is a choice between three iron supplement products: Iron dextran 50 mg/mL, Iron sucrose 20 mg/mL and Ferric gluconate 12.5 mg/mL. restrictions. Applies only to oral form of both agents. Since this is less than the threshold of total dose of 20 mg/kg, the deficit can be eliminated with a single infusion. Oral iron therapy is the first method while IV therapy comes in place when there are contraindications or the body doesnt respond to the oral one. 5. 3) Bayraktar UD, Bayraktar S. (2010) Treatment of iron deficiency anemia associated with gastrointestinal tract diseases. Iron stores are input as default 500 mg on the assumption that the patient weight is greater or equal to 35 kg (77 lbs). IDA diagnosis is based on full blood examination and on the serum ferritin level. This drug is available at the lowest co-pay. Privacy Policy, Use 500 mg for adults and children 35 kg; use 15 mg/kg if <35 kg. NOTES: Lab and/or medical tests (such as complete blood count, ferritin, transferrin, total iron binding capacity-TIBC) should be done while you are using this medication. Studies in monkeys showed concurrent use with calcium, aluminum, or iron caused significantly decreased plasma levels. Applies only to oral form of both agents. Kumpf VJ, Holland EG. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Last updated 28/06/2018 Enter values here and press 'Calculate'. Minor/Significance Unknown. Applies only to oral form of both agents. This medicine is sometimes given slowly, and the infusion can take up to 2.5 hours to complete. Iron sucrose: 20 mg/mL. If these effects continue or worsen, tell your doctor.Remember that this medication has been prescribed because your doctor has judged that the benefit to you is greater than the risk of side effects. Either increases effects of the other by pharmacodynamic synergism. Minor/Significance Unknown.iron sucrose increases levels of calcium citrate by enhancing GI absorption. Applies only to oral form of both agents. 3. Monitor Closely (1)didanosine will decrease the level or effect of iron sucrose by increasing gastric pH. Manage and view all your plans together even plans in different states. Avoid or Use Alternate Drug. https://www.uptodate.com/ (Requires subscription). Use Caution/Monitor. David McAuley, Pharm.D. ADMINISTER THE TEST DOSE AT A GRADUAL RATE OVER AT LEAST 30 SECONDS. Chandler G, Harchowel J, Macdougall I. Learn how to store and discard medical supplies safely. Compare formulary status to other drugs in the same class. Excessive therapy with parenteral iron can lead to excess storage of iron with the possibility of iatrogenic hemosiderosis. Applies only to oral form of both agents. Your dosage and length of treatment are based on your medical condition, age, and response to treatment. It is important to note that the above calculations merely provide estimates and that individual dosage should be established by a medical professional based on the current package insert for the elemental iron product used. US residents can call their local poison control center at 1-800-222-1222. The initial hemoglobin rise is more rapid with parenteral iron but on the long term (12 weeks), both therapies reach similar levels of hemoglobin. When iron sucrose was administered at deliberate overdoses to rabbit dams (up to 215 mg/kg/day) marked fetal/placental iron overload was noted. FERAHEME Dosing & Administration - Feraheme FERAHEME has flexible dosing for your patients FERAHEME flexible scheduling gives your patients the freedom to receive the iron they need as early as 3 days apart 1 FLEXIBLE DILUTION OPTIONS 1 Dilute full contents of vial (17 mL) in 50 mL to 200 mL of: 0.9% NaCl, or 5% dextrose STORAGE 1 If you have private insurance, Venofer or Monoferric may be on the list of covered medications. Monitor Closely (1)vonoprazan will decrease the level or effect of iron sucrose by inhibition of GI absorption. Alternatively the total dose may be calculated: Dose (mL) = 0.0442 (Desired Hb - Observed Hb) x LBW + (0.26 x LBW) Based on: Desired Hb = the target Hb in g/dl. Methods: We reviewed the experience of our department between January, 2011 and February, 2014 with the use of intravenous iron sucrose in children 14 years of age who failed in oral iron therapy for iron deficiency anemia (IDA). Iron sucrose: 20 mg/mL. Immune system disorders: Anaphylactic-type reactions, angioedema, Nervous system disorders: Convulsions, collapse, light-headedness, loss-of-consciousness, Respiratory, thoracic and mediastinal disorders: Bronchospasm, dyspnea, Musculoskeletal and connective tissue disorders: Back pain, swelling of the joints, General disorders and administration site conditions: Hyperhidrosis, Published studies on intravenous iron sucrose treatment after first trimester of pregnancy not shown adverse maternal or fetal outcomes; available reports of intravenous iron sucrose use in pregnant women during first trimester are insufficient to assess risk of major birth defects and miscarriage; iron deficiency anemia during pregnancy should be treated because there are risks to mother and fetus associated with untreated iron deficiency anemia (IDA) in pregnancy; risks to fetus associated with maternal severe hypersensitivity reactions, Severe adverse reactions including circulatory failure (severe hypotension, shock including in the context of anaphylactic reaction) may occur in pregnant women with parenteral iron products which may cause fetal bradycardia, especially during second and third trimester, Iron sucrose is present in human milk, and available published reports following exposure to 100-300 mg intravenous iron sucrose have not reported adverse reactions in breastfed infants; there are no data on effects on milk production, Developmental and health benefits of breastfeeding should be considered, along with mothers clinical need for treatment and any potential adverse effects on breastfed child from therapy or from underlying maternal condition.

Dan Souza Marietta Brown, Articles V